Literature DB >> 17713764

What can gallium-68 PET add to receptor and molecular imaging?

Adil Al-Nahhas, Zarni Win, Teresa Szyszko, Aviral Singh, Sameer Khan, Domenico Rubello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17713764     DOI： 10.1007/s00259-007-0568-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  35 in total

1.  Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.

Authors:  Sophia Koukouraki; Ludwig G Strauss; Vassilios Georgoulias; Michael Eisenhut; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

2.  The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma.

Authors:  Zarni Win; Lucy Rahman; Joy Murrell; Jeannie Todd; Adil Al-Nahhas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

3.  PET and planar imaging of tumor hypoxia with labeled metronidazole.

Authors:  Megumi Ito; David J Yang; Osama Mawlawi; Richard Mendez; Chang-Sok Oh; Ali Azhdarinia; Allison C Greenwell; Dong-Fang Yu; E Edmund Kim
Journal:  Acad Radiol       Date:  2006-05       Impact factor: 3.173

4.  Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.

Authors:  Tatu J Mäkinen; Petteri Lankinen; Tiina Pöyhönen; Jari Jalava; Hannu T Aro; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-09       Impact factor: 9.236

5.  68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.

Authors:  Michael Gabriel; Clemens Decristoforo; Dorota Kendler; Georg Dobrozemsky; Dirk Heute; Christian Uprimny; Peter Kovacs; Elisabeth Von Guggenberg; Reto Bale; Irene J Virgolini
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

6.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Authors:  Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2003 Jan-Feb       Impact factor: 3.488

Review 7.  Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.

Authors:  Thomas M Behr; Martin P Béhé
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

8.  DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.

Authors:  Damian Wild; Jörg S Schmitt; Mihaela Ginj; Helmut R Mäcke; Bert F Bernard; Eric Krenning; Marion De Jong; Sandra Wenger; Jean-Claude Reubi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

9.  68Ga-labeled oligonucleotides for in vivo imaging with PET.

Authors:  Anne Roivainen; Tuula Tolvanen; Satu Salomäki; Gabor Lendvai; Irina Velikyan; Petri Numminen; Maria Välilä; Hannu Sipilä; Mats Bergström; Pirkko Härkönen; Harri Lönnberg; Bengt Långström
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

Review 10.  Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.

Authors:  J C Reubi; J C Schaer; R Markwalder; B Waser; U Horisberger; J Laissue
Journal:  Yale J Biol Med       Date:  1997 Sep-Dec
View more
  18 in total

Review 1.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

Review 2.  Modular strategies for PET imaging agents.

Authors:  Jacob M Hooker
Journal:  Curr Opin Chem Biol       Date:  2009-10-31       Impact factor: 8.822

Review 3.  The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.

Authors:  Alireza Mojtahedi; Sanjay Thamake; Izabela Tworowska; David Ranganathan; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

4.  Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency.

Authors:  Ajay N Singh; Wei Liu; Guiyang Hao; Amit Kumar; Anjali Gupta; Orhan K Öz; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Bioconjug Chem       Date:  2011-07-26       Impact factor: 4.774

5.  68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.

Authors:  Gabriela Kramer-Marek; Nalini Shenoy; Jurgen Seidel; Gary L Griffiths; Peter Choyke; Jacek Capala
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

Review 6.  Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Authors:  Asha Kandathil; Ka Kit Wong; Daniel J Wale; Maria Chiara Zatelli; Anna Margherita Maffione; Milton D Gross; Domenico Rubello
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

7.  Is 68Ga-DOTATATE the answer in lung carcinoid? : Case report and review of literature.

Authors:  Amit Bhoil; Bhagwant R Mittal; Shankaramurthy Gayana; Raghava Kashyap; Anish Bhattacharya; Navneet Singh
Journal:  Lung India       Date:  2012-10

8.  Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.

Authors:  Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Journal:  Nucl Med Biol       Date:  2009-01       Impact factor: 2.408

Review 9.  Positron emission tomography imaging of prostate cancer.

Authors:  Hao Hong; Yin Zhang; Jiangtao Sun; Weibo Cai
Journal:  Amino Acids       Date:  2009-11-28       Impact factor: 3.520

Review 10.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.